ZA200107736B - Improved cancer treatment with temozolomide. - Google Patents

Improved cancer treatment with temozolomide.

Info

Publication number
ZA200107736B
ZA200107736B ZA200107736A ZA200107736A ZA200107736B ZA 200107736 B ZA200107736 B ZA 200107736B ZA 200107736 A ZA200107736 A ZA 200107736A ZA 200107736 A ZA200107736 A ZA 200107736A ZA 200107736 B ZA200107736 B ZA 200107736B
Authority
ZA
South Africa
Prior art keywords
temozolomide
cancer treatment
improved cancer
improved
treatment
Prior art date
Application number
ZA200107736A
Other languages
English (en)
Inventor
Mohamed H Ragab
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of ZA200107736B publication Critical patent/ZA200107736B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA200107736A 1999-03-30 2001-09-19 Improved cancer treatment with temozolomide. ZA200107736B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28134899A 1999-03-30 1999-03-30

Publications (1)

Publication Number Publication Date
ZA200107736B true ZA200107736B (en) 2003-02-26

Family

ID=23076905

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200107736A ZA200107736B (en) 1999-03-30 2001-09-19 Improved cancer treatment with temozolomide.

Country Status (18)

Country Link
EP (1) EP1165071B1 (no)
JP (2) JP2002540148A (no)
CN (2) CN102160864A (no)
AR (1) AR023185A1 (no)
AT (1) ATE310515T1 (no)
AU (1) AU780892B2 (no)
BR (1) BR0009380A (no)
CA (1) CA2368614C (no)
DE (1) DE60024243T2 (no)
DK (1) DK1165071T3 (no)
ES (1) ES2251987T3 (no)
HK (1) HK1044111B (no)
HU (1) HUP0200805A3 (no)
NO (1) NO330651B1 (no)
NZ (1) NZ536302A (no)
TW (1) TWI276434B (no)
WO (1) WO2000057867A2 (no)
ZA (1) ZA200107736B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100366249C (zh) * 2002-09-29 2008-02-06 天津帝士力投资控股集团有限公司 一种替莫唑胺控释给药系统
CN1742723A (zh) * 2004-09-02 2006-03-08 天津倍方科技发展有限公司 含有替莫唑胺－8－羧酸酯的药物组合物以及该类化合物用于制备抗肿瘤药物的用途
CN1299772C (zh) * 2004-10-14 2007-02-14 孔庆忠 一种抗癌药物组合物
US20060100188A1 (en) * 2004-11-09 2006-05-11 Chen Zong Treatment methods
US20070265324A1 (en) * 2006-01-17 2007-11-15 Wolfgang Wernet Combination Therapy with Parp Inhibitors
SG10201500028RA (en) * 2006-04-05 2015-02-27 Opko Health Inc Pharmaceutical formulations: salts of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same
AR061618A1 (es) * 2006-06-26 2008-09-10 Schering Corp Formas de dosificacion unitaria de temozolomida
WO2008022535A1 (fr) * 2006-08-09 2008-02-28 Tian Jin Tasly Group Co., Ltd. Composition pharmaceutique pour traiter le gliome du cerveau, son procédé et sa préparation pharmaceutique
KR101438036B1 (ko) * 2006-09-29 2014-09-04 씨아이피엘에이 엘티디. 테모졸로미드 및 유사체의 개선된 제조방법
WO2012075210A2 (en) * 2010-12-01 2012-06-07 Niiki Pharma Inc. Method for treating refractory cancer
CN102526038B (zh) * 2011-01-12 2013-09-11 北京人福军威医药技术开发有限公司 替莫唑胺的脑靶向药物组合物及其应用
CN107397735B (zh) * 2017-07-28 2020-07-10 东曜药业有限公司 一种替莫唑胺药物组合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE229343T1 (de) * 1995-10-04 2002-12-15 Schering Corp Kombination von temozolomide und alpha-interferon zur behandlung von fortgeschrittenem krebs
CA2184545A1 (en) * 1996-07-31 1998-02-01 Pascale Reidenberg Cancer treatment with temozolomide
CA2184546A1 (en) * 1996-07-31 1998-02-01 Margaret H. Dugan Method for treating pediatric high grade astrocytoma including brain stem glioma

Also Published As

Publication number Publication date
CN102160864A (zh) 2011-08-24
CA2368614A1 (en) 2000-10-05
NO330651B1 (no) 2011-05-30
ATE310515T1 (de) 2005-12-15
BR0009380A (pt) 2001-12-26
DE60024243T2 (de) 2006-08-17
HUP0200805A3 (en) 2004-07-28
AU3924400A (en) 2000-10-16
CN1345240A (zh) 2002-04-17
ES2251987T3 (es) 2006-05-16
NO20014725L (no) 2001-11-13
AR023185A1 (es) 2002-09-04
AU780892B2 (en) 2005-04-21
EP1165071A2 (en) 2002-01-02
HUP0200805A2 (hu) 2002-07-29
NO20014725D0 (no) 2001-09-28
WO2000057867A3 (en) 2001-04-19
JP2007169297A (ja) 2007-07-05
HK1044111B (zh) 2006-02-24
WO2000057867A2 (en) 2000-10-05
EP1165071B1 (en) 2005-11-23
CA2368614C (en) 2008-07-22
DE60024243D1 (de) 2005-12-29
JP2002540148A (ja) 2002-11-26
TWI276434B (en) 2007-03-21
DK1165071T3 (da) 2006-02-20
HK1044111A1 (en) 2002-10-11
NZ536302A (en) 2006-05-26

Similar Documents

Publication Publication Date Title
MXPA02002898A (es) Pirazolopirimidinas como agentes terapeuticos.
ZA200202822B (en) Oncolytic combinations for the treatment of cancer.
ZA200107736B (en) Improved cancer treatment with temozolomide.
GB9925136D0 (en) Novel treatment
ZA200105690B (en) Novel treatment.
ZA200204156B (en) Water treatment.
ZA200203166B (en) Treatment of cancer.
GB0026015D0 (en) Cancer treatment
HK1050533A1 (en) Substituted pyrroles as antiproliferative agents for the treatment of cancer.
ZA200110046B (en) Therapeutic agents.
GB0029720D0 (en) I.S machine7544232001
SI1165071T1 (sl) Izboljsano zdravljenje raka s temozolomidom
AU2001289127A1 (en) Tumor treatment
GB9804361D0 (en) Cancer treatment
AU4598100A (en) Treating cancer
GB9908176D0 (en) Cancer treatment
GB9927106D0 (en) Cancer treatment
GB9914971D0 (en) Treating cancer
GB0007254D0 (en) Treating cancer
HK1032349A1 (en) Melanoma therapy.
GB9908993D0 (en) Treatment
ZA200003586B (en) Therapeutic article.
ZA200306403B (en) Cancer treatment.
ZA200304439B (en) Therapeutic treatment.
ZA993494B (en) Chlorinator arrangement.